The DOI matches its Crossref record; 3,517 of the 3,517 references it cites were found in a registry or an index.
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 3,201–3,400 of 3,517
Nitric oxide synthase inhibitors have antidepressant-like properties in mice
Karolewicz, B., Bruce, K. H., Lee, B., & Paul, I. A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00192-2 · Cited by 28
Mellédo, J. L., Mahil, N., & Baker, G. B. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0440 · Cited by 28
Identifying and treating panic disorder in primary care.
Culpepper, L. (2004) · PubMed · Cited by 28
Lack of Sertraline Efficacy Probably Due to an Interaction With Carbamazepine
Khan, A., Shad, M. U., & Preskorn, S. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0712a · Cited by 28
Yohimbine augmentation of fluvoxamine in refractory depression: A single-blind study
Cappiello, A., McDougle, C. J., Malison, R. T., Heninger, G. R., & Price, L. H. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00367-3 · Cited by 28
Antidepressants: New pharmacological strategies
Mitchell, S. N. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00198-6 · Cited by 28
How to study consciousness scientifically1Published on the World Wide Web on 24 November 1998.1
Searle, J. R. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00047-7 · Cited by 28
Ghersi, C., Bonfanti, A., Manzari, B., Feligioni, M., Raiteri, M., & Pittaluga, A. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00129-8 · Cited by 28
GABA-mediated modification of despair behavior in mice
Alev, K. O., & Kulkarni, S. K. (1989) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00173583 · Cited by 28
Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release
Albinsson, A., Palazidou, E., Stephenson, J., & Andersson, G. K. A. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90396-4 · Cited by 28
Inhibition by Nitric Oxide of the Uptake of (3H)Serotonin into Rat Brain Synaptosomes.
Asano, S., Matsuda, T., Nakasu, Y., Maeda, S., Nogi, H., & Baba, A. (1997) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.75.123 · Cited by 28
Kier, A., Han, J., & Jacobson, L. (2004) · Endocrinology · doi:10.1210/en.2004-0650 · Cited by 28
Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists
Fredriksson, A., Palomo, T., Chase, T. N., et al. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050158 · Cited by 28
Lack of Beneficial Effects of L-Baclofen in Affective Disorder
Post, R. M., Ketter, T. A., Joffe, R. T., & KRAMLINGER, K. L. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199100640-00001 · Cited by 28
Antipsychotic Drugs: Evolving Mechanisms of Action with Improved Therapeutic Benefits
Dean, B., & Scarr, E. (2004) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007043337373 · Cited by 28
Kart, E., Jocham, G., Müller, C. P., Schlömer, C., Brandão, M. L., Huston, J. P., & Silva, M. A. D. S. (2004) · Peptides · doi:10.1016/j.peptides.2004.07.003 · Cited by 28
Mitchell, P. J., Fairhall, S. J., Fletcher, A., & Redfern, P. H. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00075-3 · Cited by 28
Birkenhäger, T. K., van den Broek, W. W., Mulder, P. G. H., Bruijn, J. A., & Moleman, P. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2060 · Cited by 28
Influence of antidepressant drugs on learning and memory paradigms in mice.
Kumar, S., & Kulkarni, S. (1996) · PubMed · Cited by 28
Augmentation of antidepressants by estrogen.
Stahl, S. M. (1998) · PubMed · Cited by 28
Thatte, U. M. (2001) · PubMed · Cited by 28
Facilitation of noradrenaline release from rat brain slices by \-adrenoceptors
Murugaiah, K., & DONNELL, J. M. O. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00171039 · Cited by 28
Ascending Projections of the Solitary Tract Nucleus
Horst, G. J. T., & Streefland, C. (2019) · CRC Press eBooks · doi:10.1201/9780429277214-8 · Cited by 28
Cognitive effects of paroxetine in older depressed patients.
Nebes, R. D., Pollock, B. G., Mulsant, B. H., Butters, M. A., Zmuda, M. D., & Reynolds, C. F. (1999) · PubMed · Cited by 28
Theohar, C., Fisher Cornelssen, K., Ho, A., Ansari, J. A., Gerlach, J., & Harper, P. A. (1981) · Cited by 28
GABAergic drugs and sexual motivation, receptivity and exploratory behaviors in the female rat
�gmo, A., & Soria, P. (1997) · Psychopharmacology · doi:10.1007/s002130050203 · Cited by 27
Bianca, R. D. D. V., Sorrentino, R., Roviezzo, F., Imbimbo, C., Palmieri, A., Dominicis, G. D., Montorsi, F., Cirino, G., & Mirone, V. G. (2004) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901293 · Cited by 27
Lejeune, F., & Millan, M. J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00222.x · Cited by 27
Self-citationSerotonergic and histaminergic mechanisms involved in intralipid drinking?
Hartfield, A. W., Moore, N. A., & Clifton, P. G. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00221-1 · Cited by 27
Biphasic role of dopamine on female sexual behaviour via D2 receptors in the mediobasal hypothalamus
Fabre‐Nys, C., Chesneau, D., de la Riva, C., Hinton, M. R., Locatelli, A., Ohkura, S., & Kendrick, K. M. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00410-0 · Cited by 27
Presynaptic induction and expression of NMDA-dependent LTP
Paré, D. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.05.004 · Cited by 27
Differential effects of chronic antidepressant treatments on μ- and δ-opioid receptors in rat brain
Vilpoux, C., Carpentier, C., Leroux‐Nicollet, I., Naudon, L., & Costentin, J. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01585-6 · Cited by 27
α2-Adrenoceptor modulation of long-term potentiation elicited in vivo in rat occipital cortex
Mondaca, M., Hernández, A., Pérez, H., Valladares, L., Sierralta, W. D., Fernández, V., & Soto‐Moyano, R. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.020 · Cited by 27
Newman‐Tancredi, A., Cussac, D., Brocco, M., Rivet, J., Chaput, C., Touzard, M., Pasteau, V., & Millan, M. J. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02927-4 · Cited by 27
Self-citationAbi‐Saab, W., Seibyl, J. P., D’Souza, C., Karper, L. P., Gueorgueva, R., Abi‐Dargham, A., Wong, M., Rajhans, S., Erdos, J., Heninger, G. R., et al. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1057-7 · Cited by 27
Wortley, K. E., Hughes, Z. A., Heal, D. J., & Stanford, S. C. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702720 · Cited by 27
Bezin, L., Marcel, D., Desgeorges, S., Pujol, J. F., & Weissmann, D. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00007-3 · Cited by 27
Hogan, J. B., Hodges, D. B., Lelas, S., Gilligan, P. J., McElroy, J. F., & Lindner, M. D. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2028-y · Cited by 27
Tuma, J., Strubbe, J. H., STRUBBE, J. H., Mocaër, E., & Koolhaas, J. M. (2001) · Chronobiology International · doi:10.1081/cbi-100107514 · Cited by 27
Treatment strategies for sleep disturbance in patients with depression.
Doghramji, K. (2003) · PubMed · Cited by 27
Rogóż, Z., Skuza, G., Wójcikowski, J., Daniel, W. A., Wróbel, A., Dudek, D., & Zięba, A. (2004) · PubMed · Cited by 27
The efficacy of intramuscular tramadol as a rapid-onset antidepressant
Spencer, C. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/000486700284 · Cited by 27
Dresse, A., & Scuvée‐Moreau, J. (1988) · PubMed · Cited by 26
Circadian Rhythms and Psychiatric Disorders in the Elderly
Sloan, E. P., Flint, A. J., Reinish, L. W., & Shapiro, C. M. (1996) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879600900402 · Cited by 26
Allosteric modulation of neurotransmitter transporters at excitatory synapses
Vandenberg, R. J., Ju, P., Aubrey, K. R., Ryan, R. M., & Mitrovic, A. D. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.05.006 · Cited by 26
Hatanaka, K.-I., Yatsugi, S., & Yamaguchi, T. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00173-4 · Cited by 26
Yamada, J., & Sugimoto, Y. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01240-7 · Cited by 26
Effects of REM sleep deprivation on central α1- and β-adrenoceptors in rat brain
Mogilnicka, E. M., Przewo̵cka, B., van Luijtelaar, E. L. J. M., Klimer, V., & Coenen, A. M. L. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90004-3 · Cited by 26
Sørensen, E., Grønli, J., Bjorvatn, B., Bjørkum, A. A., & Ursin, R. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02101-1 · Cited by 26
Materi, L. M., & Semba, K. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01619.x · Cited by 26
Richardson, T. A., & Robinson, R. D. (2000) · Primary Care Update for OB/GYNS · doi:10.1016/s1068-607x(00)00049-4 · Cited by 26
Amtage, F., Neughebauer, B., McIntosh, J. M., Freiman, T. M., Zentner, J., Feuerstein, T. J., & Jackisch, R. (2003) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2003.11.002 · Cited by 26
Ciusani, E., ZULLINO, D. F., Eap, C. B., Brawand-Amey, M., Brocard, M., & Baumann, P. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800414 · Cited by 26
Brain neurosteroid changes after paroxetine administration in mice
Nechmad, A., Maayan, R., Spivak, B., Ramadan, E., Poyurovsky, M., & Weizman, A. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00015-4 · Cited by 26
The Concept of Population Prevention: Application to Schizophrenia
Mojtabai, R., Malaspina, D., & Susser, E. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007047 · Cited by 26
Qualitative review of SNRIs in anxiety.
Silverstone, P. H. (2004) · PubMed · Cited by 26
Functional coupling of serotonin and noradrenaline transporters
Horschitz, S., Hummerich, R., & Schloss, P. D. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01899.x · Cited by 25
Bachmann, C. G., Bilang‐Bleuel, A., Carli, S. D., Linthorst, A. C. E., & Reul, J. M. H. M. (2005) · Neuroendocrinology · doi:10.1159/000086413 · Cited by 25
Nandi, A., Dersch, C. M., Kulshrestha, M., Ananthan, S., & Rothman, R. B. (2004) · Synapse · doi:10.1002/syn.20048 · Cited by 25
Li, L., Cui, X., & Reith, M. E. A. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-001-0526-6 · Cited by 25
Birthelmer, A., Ehret, A., Amtage, F., Förster, S., Lehmann, O., Jeltsch‐David, H., Cassel, J., & Jackisch, R. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00930-9 · Cited by 25
Kim, S. Y. H., & Holloway, R. G. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1272 · Cited by 25
KIM, H., Choi, J., Lee, Y. S., SHIM, E., HONG, S., KIM, M., Min, D. S., Rhie, D., KIM, M., & Jo, Y. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.03.007 · Cited by 25
Suzuki, E., Nakaki, T., Shintani, F., Kanba, S., & Miyaoka, H. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01035-2 · Cited by 25
Intracellular signalling and cancer: complex pathways lead to multiple targets
Bell, H. S., & Ryan, K. M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.10.022 · Cited by 25
Ligand-Independent Activation of Progestin Receptors in Sexual Receptivity
Mani, S. K. (2001) · Hormones and Behavior · doi:10.1006/hbeh.2001.1687 · Cited by 25
Gamble, K. L., Ehlen, J. C., & Albers, H. E. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.03.004 · Cited by 25
Modulation of learned helplessness by 5-hydroxytryptamine2A receptor antisense oligodeoxynucleotides
Papolos, D. F., Yu, Y.-M., Rosenbaum, E., & Lachman, H. M. (1996) · Psychiatry Research · doi:10.1016/0165-1781(96)02935-6 · Cited by 25
Brady, L. S., Lynn, A. B., Glowa, J. R., Le, D. Q., & Herkenham, M. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117444 · Cited by 25
Blank, T., Nijholt, I. M., Vollstaedt, S., & Spiess, J. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00244-9 · Cited by 25
Sabbe, B., Hulstijn, W., Maes, M. H. J., Pier, M., Scharpé, S., & Zitman, F. G. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00326-2 · Cited by 25
Possible Genomic Consequence of Nongenomic Action of Glucocorticoids in Neural Cells
Chen, Y.-Z., & Qiu, J. (2001) · Physiology · doi:10.1152/physiologyonline.2001.16.6.292 · Cited by 25
Serum Thyrotropin Concentrations and Bioactivity During Sleep Deprivation in Depression
Orth, D. N., Shelton, R. C., Nicholson, W. E., Beck‐Peccoz, P., Tomarken, A. J., Persani, L., & Loosen, P. T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.1.77 · Cited by 25
Thyroid Indices and Response to Fluoxetine and Nortriptyline in Major Depression
Gendall, K. A., Joyce, P. R., Mulder, R., & Luty, S. E. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103174001 · Cited by 25
Neuroendocrinology of Neurodegenerative Diseases
de Aguilar, J. G., René, F., Dupuis, L., & Loeffler, J. (2003) · Neuroendocrinology · doi:10.1159/000074445 · Cited by 24
Sokal, D. M., & Chapman, V. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03255-4 · Cited by 24
Zhang, H., Frith, S. A., Wilkins, J., & O’Donnell, J. M. (2001) · Psychopharmacology · doi:10.1007/s002130100889 · Cited by 24
Gómez‐Gil, E., Gastó, C., Carretero, M., Díaz‐Ricart, M., Salamero, M., Navinés, R., & Escolar, G. (2004) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.583 · Cited by 24
McQuade, R., Leitch, M. M., Gartside, S. E., & Young, A. H. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104047276 · Cited by 24
DeBattista, C., Sofuoglu, M., & Schatzberg, A. F. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00161-9 · Cited by 24
Inverse agonism at α2-adrenoceptors in native tissue
Murrin, L. C., Gerety, M. E., Happe, H. K., et al. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00317-4 · Cited by 24
Yamada, K., Yagi, G., & Kanba, S. (2003) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2003.01099.x · Cited by 24
Mulholland, P. J., Self, R. L., Harris, B. R., Littleton, J. M., & Prendergast, M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.02.007 · Cited by 24
Drug-Induced Depression: Incidence, Avoidance and Management
Patten, S. B., & Love, E. J. (1994) · Drug Safety · doi:10.2165/00002018-199410030-00003 · Cited by 24
Mechanisms of Agonist Action at D2 Dopamine Receptors
Roberts, D. J., Lin, H., & Strange, P. G. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.004077 · Cited by 24
5‐ht5B Receptor mRNA in the raphe nuclei: Coexpression with serotonin transporter
Serrats, J., Raurich, A., Vilaró, M. T., Mengod, G., & Cortés, R. (2003) · Synapse · doi:10.1002/syn.10287 · Cited by 24
Nicotine produces antidepressant-like actions: Behavioral and neurochemical evidence
Popik, P., Krawczyk, M., Kos, T., Nalepa, I., Kowalska, M., Witarski, T., Antkiewicz‐Michaluk, L., & Vetulani, J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.04.009 · Cited by 24
Inhibition of amino acid release by 5-HT1B receptor agonist in the rat prefrontal cortex.
Gołembiowska, K., & Dziubina, A. (2002) · PubMed · Cited by 24
Antagonists at the neurokinin receptors--recent patent literature.
Giardina, G. A. M., Gagliardi, S., & Martinelli, M. (2003) · PubMed · Cited by 23
Pilc, A., Kłodzińska, A., & Nowak, G. (2002) · Drugs of the Future · doi:10.1358/dof.2002.027.08.687386 · Cited by 23
Lasting impressions: Motifs in protein–protein maps may provide footprints of evolutionary events
Rice, J. J., Kershenbaum, A., & Stolovitzky, G. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500130102 · Cited by 23
The combination of olanzapine and fluoxetine in mood disorders
Shelton, R. C. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.7.1175 · Cited by 23
Webster, M. J., O'Grady, J., Orthmann, J., & Weickert, C. S. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(00)90567-x · Cited by 23
Losada, M. E. O., & Rubio‐Terres, C. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00511408 · Cited by 23
Owen, J. C. E., & Whitton, P. S. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706188 · Cited by 23
An NK1 receptor antagonist affects the circadian regulation of locomotor activity in golden hamsters
Challet, É., Naylor, E., Metzger, J. M., MacIntyre, D. E., & Turek, F. W. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00491-0 · Cited by 23
Emerging Ethical Issues in Pharmacogenomics: From Research to Clinical Practice
Freund, C. L., & Wilfond, B. S. (2002) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200202040-00007 · Cited by 23
Nakamura, K., & Kurasawa, M. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000222 · Cited by 23
Kitaichi, Y., Inoue, T., Nakagawa, S., Izumi, T., & Koyama, T. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.04.038 · Cited by 23
Roses, A. D. (2002) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500126 · Cited by 23
Agnati, L. F., Ferré, S., Burioni, R., Woods, A. S., Genedani, S., Franco, R., & Fuxé, K. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:1-2:061 · Cited by 23
Delta opioid inhibition of light-induced phase advances in hamster circadian activity rhythms
Tierno, A., Fiore, P., & Gannon, R. L. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02468-x · Cited by 23
Katz, M. M., Halbreich, U. M., Bowden, C. L., Frazer, A., Pinder, R. M., Rush, A. J., Wheatley, D., & Lebowitz, B. D. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00329-9 · Cited by 23
Fluoxetine blocks cloned neuronal A-type K+ channels Kv1.4
Choi, B. H., Choi, J., Ahn, H. S., Kim, M.-J., Rhie, D., Yoon, S.-H., Min, D., Jo, Y., Kim, M., & Hahn, S. J. (2003) · Neuroreport · doi:10.1097/00001756-200312190-00032 · Cited by 23
Hegerl, U., Mergl, R., Henkel, V., Pogarell, O. M., Muller-Siecheneder, F., Frodl, T., & Juckel, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1983-7 · Cited by 23
Pharmacological mechanisms of T3 augmentation of antidepressant action
Newman, M. E., Agid, O., Gur, E., & Lerer, B. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145700001875 · Cited by 23
Tringali, G., Aubry, J. M., Moscianese, K., Zamori, C., Vairano, M., Preziosi, P., Navarra, P., & Pozzoli, G. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0445 · Cited by 23
The human body circadian: How the biologic clock influences sleep and emotion.
Cardinali, D. P. (2000) · PubMed · Cited by 23
Putative Common Pathways in Therapeutic Brain Stimulation for Affective Disorders
Bolwig, T. G. (2003) · CNS Spectrums · doi:10.1017/s1092852900018964 · Cited by 23
Treatment-Resistant Depression
Young, M. (2018) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2018.01.003 · Cited by 23
Role of norepinephrine in the dorsomedial hypothalamic panic response
Shekhar, A., Katner, J., Sajdyk, T. J., & Kohl, R. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00688-8 · Cited by 22
Lieb, K., Treffurth, Y., Hamke, M., Akundi, R. S., Kleinsorgen, M. V., & Fiebich, B. L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01802.x · Cited by 22
Adachi, H., Sato, Y., Kato, R., Hisasue, S., Suzuki, K., Masumori, N., Itoh, N., & Tsukamoto, T. (2003) · The Journal of Urology · doi:10.1016/s0022-5347(05)64133-x · Cited by 22
Aouizerate, B., Martin‐Guehl, C., Cuny, E., Guehl, D., Amieva, H., Benazzouz, A., Fabrigoule, C., Allard, M., Rougier, A., Burbaud, P., et al. (2005) · médecine/sciences · doi:10.1051/medsci/20052110811 · Cited by 22
Heilbronner, U., van Kampen, M., & Flügge, G. (2004) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-6921-z · Cited by 22
Endocrinological effects of mirtazapine in healthy volunteers
Schüle, C., Baghai, T. C., Bidlingmaier, M., Strasburger, C. J., & Laakmann, G. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00264-6 · Cited by 22
Moreau, X. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00234-7 · Cited by 22
Lithium and desipramine versus desipramine alone in the treatment of severe major depression
Cappiello, A., McDougle, C. J., Delgado, P. L., Malison, R. T., Jatlow, P., Charney, D. S., Heninger, G. R., & Price, L. H. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199809000-00001 · Cited by 22
Caldecott-Hazard, S., Guzé, B. H., Kling, M. A., Kling, A. S., & Baxter, L. R. (1991) · Synapse · doi:10.1002/syn.890080306 · Cited by 22
Behavioural, neural and cardiovascular adaptations in mice lacking the NPY Y1 receptor
Costoli, T., Sgoifo, A., Stilli, D., Flügge, G., Adriani, W., Giovanni Laviola, A., Fuchs, E., Pedrazzini, T., & Musso, E. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.09.016 · Cited by 22
Katz, M. M., Houston, J., Brannan, S., Bowden, C. L., Berman, N., Swann, A. C., & Frazer, A. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004407 · Cited by 22
Neurochemical and metabolic aspects of antidepressants: an overview.
Baker, G. B., Coutts, R. T., & Greenshaw, A. J. (2000) · PubMed · Cited by 22
Seo, D. O., Shin, C. Y., Lee, C. J., Dailey, J. W., Reith, M. E. A., Jobe, P. C., & Ko, K. H. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00856-5 · Cited by 22
Lapierre, Y. D., Silverstone, P. H., Reesal, R. T., Saxena, B. M., Turner, P., Bakish, D., Plamondon, J., Vincent, P. M., Remick, R. A., Kroft, C. D. L., et al. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199808000-00002 · Cited by 22
Refractory depression: treatment strategies, with particular reference to the thyroid axis.
Joffe, R. T. (1997) · PubMed · Cited by 21
Assessment of excessive sleepiness and insomnia as they relate to circadian rhythm sleep disorders.
Doghramji, K. (2004) · PubMed · Cited by 21
Review: Vasopeptidase inhibitors
Sagnella, G. A. (2002) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2002.023 · Cited by 21
Clinical pharmacology of befloxatone: a brief review
Rosenzweig, P., Patat, A. A., Curet, O., Durrieu, G., Dubruc, C., Zieleniuk, I., & Legangneux, E. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00226-2 · Cited by 21
Sokal, D. M., & Chapman, V. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04057-x · Cited by 21
Novel neuronal targets for the acetylcholinesterase inhibitor donepezil
Sortino, M. A., Frasca, G., Chisari, M., Platania, P., Chiechio, S., Vancheri, C., Copani, A., & Canonico, P. L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.011 · Cited by 21
Lorrain, D. S., Baccei, C. S., Correa, L. D., & Bristow, L. J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.022 · Cited by 21
Gardner, M. E., Malone, D. C., Sey, M., & Babington, M. A. (2004) · Journal of the American Medical Directors Association · doi:10.1016/s1525-8610(04)70063-8 · Cited by 21
Functional importance of the C‐terminus of the human norepinephrine transporter
Distelmaier, F., Wiedemann, P., Brüss, M., & Bönisch, H. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02729.x · Cited by 21
Maier, W., & Benkert, O. (1994) · Psychopharmacology · doi:10.1007/bf02245573 · Cited by 21
Developmental exaptation and evolutionary change
Chipman, A. D. (2001) · Evolution & Development · doi:10.1046/j.1525-142x.2001.01033.x · Cited by 21
A Critical Review of Published Economic Modelling Studies in Depression
Jones, M. T., & Cockrum, P. C. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017060-00003 · Cited by 21
Augmentation of standard depression therapy
Marangell, L. B. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80071-5 · Cited by 21
Strategies for Multiple Signalling Inhibition
Tortora, G., Bianco, R., & Daniele, G. (2004) · Journal of Chemotherapy · doi:10.1179/joc.2004.16.supplement-1.41 · Cited by 21
Pälvimäki, E.-P., Majasuo, H., Syvälahti, E. K. G., & Hietala, J. A. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2004.11.005 · Cited by 21
Chen, F., & Lawrence, A. J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068692 · Cited by 21
Li, Y., Qian, Y., Yu, X., Wang, Y., Dong, D.-G., Sun, W., Ma, R.-M., & Su, B. (2004) · Molecular Biology and Evolution · doi:10.1093/molbev/msh220 · Cited by 21
Klein, N., Sacher, J., Wallner, H., Tauscher, J. T., & Kasper, S. F. (2004) · CNS Spectrums · doi:10.1017/s1092852900002248 · Cited by 21
Millan, M. J., Rivet, J., Gobert, A., Canton, H., Veiga, S., & Bervoets, K. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38665-9 · Cited by 21
Self-citationOptimizing antidepressant treatment: efficacy and tolerability
Deakin, J. F. W., & Dursun, S. M. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200206001-00003 · Cited by 21
Bschor, T., Baethge, C., Adli, M., Lewitzka, U., Eichmann, U., & Bauer, M. (2003) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0326 · Cited by 21
Hofer, A., Hummer, M., Kemmler, G., Kurz, M., Kurzthaler, I., & Fleischhacker, W. W. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003456 · Cited by 21
Öz, M., Zhang, L., Rotondo, A., Sun, H., & Morales, M. (2003) · Synapse · doi:10.1002/syn.10273 · Cited by 21
Precision and Comparability of Adverse Event Rates of Newer Antidepressants
Vida, S., & Looper, K. J. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199910000-00005 · Cited by 21
Uncomplicated and Comorbid Obsessive-Compulsive Disorder in an Epidemiologic Sample
Hollander, E., Greenwald, S., Neville, D., Johnson, J., Hornig, C. D., & Weissman, M. M. (1998) · CNS Spectrums · doi:10.1017/s1092852900007148 · Cited by 21
Grandoso, L., Torrecilla, M., Pineda, J., & Ugedo, L. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.05.033 · Cited by 20
Molina-Hernández, M., Téllez-Alcántara, N. P., García, J. P., Lopez, J. I. O., & Jaramillo, M. T. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.08.006 · Cited by 20
Taylor, F. B., & Prather, M. R. (2003) · Depression and Anxiety · doi:10.1002/da.10115 · Cited by 20
Portugal-Santana, P., Doretto, M. C., Tatsuo, M. A. K. F., & Duarte, I. D. G. (2004) · Brain Research · doi:10.1016/j.brainres.2003.09.083 · Cited by 20
Duncan, W. C., Johnson, K. A., & Wehr, T. A. (1998) · Journal of Biological Rhythms · doi:10.1177/074873098129000165 · Cited by 20
Pharmacology of α-Adrenoceptors in Male Sexual Function
Rampin, O. (1999) · European Urology · doi:10.1159/000052329 · Cited by 20
Contoreggi, C. S., Rice, K. C., & Chrousos, G. P. (2004) · Neuroendocrinology · doi:10.1159/000081785 · Cited by 20
α2a and α2c adrenoceptors on spinal neurons controlling penile erection
Yaici, E. D., Rampin, O., Calas, A., Jestin, A., McKenna, K. E., Leclerc, P. M., Benoît, G., & Giuliano, F. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00367-6 · Cited by 20
Björklund, M., Siverina, I., Heikkinen, T., Tanila, H., Sallinen, J., Scheinin, M., & Riekkinen, P. J. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00209-3 · Cited by 20
Semba, J., Kuroda, Y., & Takahashi, R. (2008) · Neuropsychobiology · doi:10.1159/000118569 · Cited by 20
Fiore, M., Angelucci, F., Aloe, L., Iannitelli, A., & Korf, J. (2003) · Current Neuropharmacology · doi:10.2174/1570159033477206 · Cited by 20
Ginovart, N., Marcel, L., Bezin, L., Garcia, C., Gagne, C., Pujol, J. F., & Weissmann, D. (1996) · Brain Research · doi:10.1016/0006-8993(96)00074-1 · Cited by 20
Bailey, S., Dhillon, A., Woodhall, G. L., & Jones, R. S. G. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.07.001 · Cited by 20
Allosteric modulation of G protein-coupled receptors
IJzerman, A. P., Kourounakis, A. P., & van der Klein, P. (2001) · Il Farmaco · doi:10.1016/s0014-827x(01)01015-1 · Cited by 20
Pharmacological Characterization of the Discriminative Stimulus Effects of Clenbuterol in Rats
O’Donnell, J. J. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00038-5 · Cited by 20
A study of the brain structures involved in the acute effects of fluoxetine on REM sleep in the rat
Monti, J. M., & Jantos, H. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004511 · Cited by 20
Effects of Antidepressants in Rats Trained to Discriminate Centrally Administered Isoproterenol
Crissman, A. M., & O’Donnell, J. M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034686 · Cited by 20
Ordway, G. A., & Szebeni, K. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004468 · Cited by 20
Karalis, V. D., Tsantili‐Kakoulidou, A., & Macheras, P. E. (2002) · Pharmaceutical Research · doi:10.1023/a:1021489323828 · Cited by 20
Pharmacotherapy of Seasonal Affective Disorder
Pjrek, E., Winkler, D., & Kasper, S. F. (2005) · CNS Spectrums · doi:10.1017/s1092852900019623 · Cited by 20
Aizenberg, D., Naor, S., Zemishlany, Z., & Weizman, A. (1999) · PubMed · Cited by 20
Valentini, V., Cacciapaglia, F., Frau, R., & Chiara, G. D. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03030.x · Cited by 19
Study of mirtazapine antidepressant effects in rats
Rauggi, R., Cassanelli, A., Raone, A., Tagliamonte, A., & Gambarana, C. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005146 · Cited by 19
Perez, M., Pauwels, P. J., Pallard, I., Fourrier, C., Chopin, P., Palmier, C., Colovray, V., & Halazy, S. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00619-2 · Cited by 19
Yamada, J., & Sugimoto, Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03684-3 · Cited by 19
Antidepressant and depressogenic drugs lack consistent effects on hamster circadian rhythms
Klemfuss, H., & Kripke, D. F. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90108-2 · Cited by 19
Zhang, H., Huang, Y., & O’Donnell, J. M. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1512-0 · Cited by 19
Fujihara, H., Serino, R., Ueta, Y., Séi, H., & Morita, Y. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.09.005 · Cited by 19
Nitric oxide involvement in the anxiogenic-like effect of substance P
Baretta, I. P., Assreuy, J., & de Lima, T. C. M. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00165-6 · Cited by 19
Gamble, K. L., Novak, C. M., & Albers, H. E. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.04.018 · Cited by 19
Gur, E., Lifschytz, T., Lerer, B., & Newman, M. E. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02642-0 · Cited by 19
Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors.
Rogoz, Z., Wróbel, A., Dlaboga, D., Maj, J., & Dziedzicka‐Wasylewska, M. (2002) · PubMed · Cited by 19
A comparative study of milnacipran and imipramine in the treatment of major depressive disorder
López-Ibor, J. J., Conesa, A., & the Spanish Milnacipran/Imipramine Group (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125003719 · Cited by 19
Managing mood disorders and comorbid personality disorders.
Bajaj, P., & Tyrer, P. J. (2005) · PubMed · Cited by 19
Histamine-selective H3 receptor ligands and cognitive functions: an overview.
Vohora, D. (2004) · PubMed · Cited by 19
Sorbera, L. A., Rabasseda, X., Silvestre, J. S., & Castañer, J. (2001) · Drugs of the Future · doi:10.1358/dof.2001.026.03.611242 · Cited by 19
Moreira, F. A., & Guimar�es, F. S. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1910-y · Cited by 18
Baldwin, D. S., Hawley, C. J., Mellors, K., & On behalf of the CN104-070 study group (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500303 · Cited by 18
Reith, M. E. A., Wang, L. C., & Dutta, A. K. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.09.015 · Cited by 18
Facilitative effect of a novel AVP fragment analog, NC-1900, on memory retention and recall in mice
Sato, T., Tanaka, K., Teramoto, T., Ohnishi, Y., Hirate, K., Irifune, M., & Nishikawa, T. (2004) · Peptides · doi:10.1016/j.peptides.2004.04.001 · Cited by 18
Deken, S. L., Beckman, M. L., & Quick, M. W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01933-0 · Cited by 18
Antagonism of selective serotonin reuptake inhibitor-induced nausea by mirtazapine
Pedersen, L., & Klysner, R. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199701000-00009 · Cited by 18
Détári, L., Szentgyörgyi, V., Hajnik, T., Szénási, G., Gacsályi, I., & Kukorelli, T. (1999) · Psychopharmacology · doi:10.1007/s002130050895 · Cited by 18
Dursun, S. M., & Devarajan, S. (2000) · Psychopharmacology · doi:10.1007/s002130000579 · Cited by 18
Boschmann, M., Frenz, U., Murphy, C., & Noack, R. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02049-7 · Cited by 18
Medved, V., Petrović, R., Išgum, V., Szirovicza, L., & Hotujac, L. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00172-5 · Cited by 18
Bermack, J. E., Haddjeri, N., & Debonnel, G. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.066472 · Cited by 18
Nefazodone in Major Depression: Adjunctive Benzodiazepine Therapy and Tolerability
Rickels, K., Schweizer, E. E., CASE, W. G., DeMartinis, N. A., Greenblatt, D. J., Mandos, L. A., & Espana, F. G. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199804000-00007 · Cited by 18
Nickola, T. J., Ignatowski, T. A., Reynolds, J. L., & Spengler, R. N. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29585-9 · Cited by 18
Plotting the course to remission: the search for better outcomes in the treatment of depression.
Burt, V. K. (2004) · PubMed · Cited by 17
In quest of thyroid hormone function in mature mammalian brain.
Sarkar, P. (2002) · PubMed · Cited by 17
Cited by
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Metadata
- Authors
- Millan, M. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 110
- Issue
- 2
- Pages
- 135-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2073570537
- Cited by
- 551
- References
- 3,517
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.